The global 𝐨𝐫𝐚𝐥 𝐯𝐚𝐜𝐜𝐢𝐧𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 is poised for remarkable growth, with revenue anticipated to soar from 𝐔𝐒𝐃 𝟑,𝟗𝟖𝟓.𝟗 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟒 𝐭𝐨 𝐔𝐒𝐃 𝟖,𝟖𝟎𝟎 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟑. This growth reflects a strong compound annual growth rate (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟗.𝟐% over the forecast period. This significant expansion underscores the increasing adoption of oral vaccines as a pivotal tool in combating infectious...